Prevalence of CMV antibodies in blood donors of Sfax region (advantage in blood transfusion);Prevalence des anticorps anti-CMV chez les donneurs de sang de la region de Sfax (interet en transfusion sanguine)

Tunisie Medicale

Volumn 78, Issue 8-9, 2000, Pages 512-517

  Gargouri, Jalel ^b   Elleuch, Habib ^b   Karray, Hela ^a   Rekik, Hayet ^b   Hammami, Adnene ^b  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b NONE

Author keywords

Blood transfusion; CMV antibodies; Cytomegalovirus

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; LEUKAPHERESIS; MALE; METHODOLOGY; MIDDLE AGED; SEX RATIO; STATISTICS; TUNISIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LEUKAPHERESIS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; TUNISIA;

EID: 0347074632     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. HOANG B., LE XUAN P., GUICHOUX P. et coll. - Prévalence des anticorps anticytomégalovirus dans une population de donneurs de sang de la région parisienne. - Rev. Fr. Transfus. Hémobiol., 1991, 34: 119-130.
2. MICHELSON S. - Cytomégalovirus humain (CMV) .- Cours sur le cytomegalovirus humain (cours de virologie médicale),Institut Pasteur, France, 1993.
3. LANG D.J., EBERT A., RODGERS B.M. et al.- Reduction of post-perfusion cytomegalovirus infections following the use of leukocyte depleted blood.- Transfusion, 1977, 17: 391.
4. DEMMLER G.J., BRADY M.T., BIJOU H. et al.- Post-transfusion cytomegalovirus infection in neonates: role of saline-washed red blood cells.- J. Pediatr., 1986, 108: 762.
5. WILLIAMS A.E., Mc DONALD M., LUBAN N.L.C. et al. - Low incidence of neonatal post-transfusion cytomegalovirus infection associated with the use of washed red blood cell product.-Transfusion, 1984, 24: 430.
6. LUBAN N.L.C., WILLIMAS A.E., Mc DONALD M.G. et al. - Low incidence of acquired cytomegalovirus infection in neonates transfused with washed red blood cells. - A.J.D.C., 1987, 141: 416.
7. PREIKSAITIS J.K., BROWN L., Mc KENZIE M. - Transfusion acquired cytomegalovirus infection in neonates. A prospective study. - Transfusion, 1988, 28: 205.
8. ADLER S.P., CHANDRIKA T., LAWRENCE L. et al.-Cytomégalovirus infections in neonates acquired by blood transfusions. - Pediatr. Infect. Dis., 1983, 2: 114-118.
9. BETTS R.F., CESTERO R.V.M., FREEMAN R.B. et al. -Epidemiology of cytomegalovirus infection in end stage renal disease. - J. Med. Virol., 1979, 4: 89.
10. TOLKOF-RUBIN N.E., RUBIN R.H., KELLER E.E. et al. -Cytomegalovirus infection of dialysis patients and personnel. -Ann. Intern. Med., 1978, 89: 625-28.
11. BRADY M.T., MILAM J.D., ANDERSON D.C. et al.- Use of deglycerolized red blood cells to prevent posttransfusion infection with cytomegalovirus in neonates.- J. Infect. Dis., 1984, 150: 334.
12. KIM H.C., SPITZER A.R., PLOTKIN S.- The role of frozen-thawed-washed red blood cells in preventing transfusion acquired CMV infection in the neonate.- Transfusion, 1985, 25: 472.
13. SIMON T.L., JOHNSON J.D., KOFFLER H. et al.- Impact of previously frozen deglycerolized red blood cells on cytomegalovirus transmission to newborn infants. - Plasma ther. Transfus. Technol., 1987, 8: 51.
14. TAYLOR B.J., JACOBS R.F., BAKER R.L. et al.- Frozen deglycerolized blood prevent transfusion acquired cytomegalovirus infection in neonates. - Pediatr. Infection Dis., 1986, 5: 188.
15. ANDREU G., MARINIERE A.M., FRETZ C. et coll.- Infections à cytomégalovirus post-transfusionnelles: incidence et moyens de prévention. - Rev. Fr. Transfus. Hémobiol., 1991, 34: 213-232.
16. GRAAN-HENTZEN Y.C.E. De, GRATAMA J.W., MUDDE G.C. et al. - Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive with cell depletion of blood products. - Transfusion, 1989, 29: 757-60.
17. MURPHY M.F., GRINT P.C.A., HARDIMAN A.E. et al. - Use of leucocyte poor blood components to prevent primary cytomegalovirus infection in patients with acute leukemia. - Brit. J. Hematol., 1988, 70: 253.
18. VERDONCK L.F., DE GRAAN-HENTZEN Y.C.E., DEKKER A.W. et al. - Cytomegalovirus seronegative platelets and leucocyte poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation. - Bone Marrow Transplantation, 1987, 2: 73-78.
19. BOWDEN R.A., SAYERS M., CAYS M. et al.- The role of blood product filtration in the prevention of transfusion associated cytomegalovirus infection after bone marrow transplantation. - Transfusion, 1989, 29: 57s.
20. ANDREU G., MASSE M., LECRUBIER C.- Evaluation of new leucocyte removal filter for platelet concentrates: sepacell PL 10-N. - Transfusion, 1989, 29, 40s.